Sonendo Inc
NYSE:SONX
Sonendo Inc
Additional Paid In Capital
Sonendo Inc
Additional Paid In Capital Peer Comparison
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sonendo Inc
NYSE:SONX
|
Additional Paid In Capital
$458.4m
|
CAGR 3-Years
262%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Additional Paid In Capital
$19.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
25%
|
|
Boston Scientific Corp
NYSE:BSX
|
Additional Paid In Capital
$20.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
Stryker Corp
NYSE:SYK
|
Additional Paid In Capital
$2.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Additional Paid In Capital
$8.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
See Also
What is Sonendo Inc's Additional Paid In Capital?
Additional Paid In Capital
458.4m
USD
Based on the financial report for Dec 31, 2023, Sonendo Inc's Additional Paid In Capital amounts to 458.4m USD.
What is Sonendo Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 3Y
262%
Over the last year, the Additional Paid In Capital growth was 2%. The average annual Additional Paid In Capital growth rates for Sonendo Inc have been 262% over the past three years .